BURLINGTON, Mass., Nov. 8, 2023
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal
fourth quarter and full year 2023 earnings which ended on
September 30, 2023 on Monday, November 13, 2023 after the market
closes.
The Company will host a conference call and live webcast to
discuss its financial results on the same day, Monday, November 13, 2023, at 4:30 p.m. Eastern Time. To participate in the
conference call, please dial 800-757-9216 for domestic callers and
+1-212-231-2939 for international callers.
Analysts, investors and members of the media can access the live
webcast via the Azenta website at
https://investors.azenta.com/events. A replay will be available
beginning at 8:30 a.m. ET on
November 14, 2023.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA)
is a leading provider of life sciences solutions worldwide,
enabling impactful breakthroughs and therapies to market faster.
Azenta provides a full suite of reliable cold-chain sample
management solutions and multiomics services across areas such as
drug development, clinical research and advanced cell therapies for
the industry's top pharmaceutical, biotech, academic and healthcare
institutions globally. Our global team delivers and supports these
products and services through our industry-leading brands,
including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro,
Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations
in North America, Europe and Asia. For more
information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-announces-fiscal-2023-fourth-quarter-and-full-year-earnings-conference-call-and-webcast-301982343.html
SOURCE Azenta